Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus? | Zendy

Serdar Şahin | Zendy; Özlem Haliloğlu | Zendy; Özge Polat Korkmaz | Zendy; Emre Durcan | Zendy; Humeyra Rekali Sahin | Zendy; Volkan Yumuk | Zendy; Taner Damcı | Zendy; Hasan İlkova | Zendy; Zeynep Oşar Şiva | Zendy

Open Access

Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Author(s) -

Serdar Şahin,

Özlem Haliloğlu,

Özge Polat Korkmaz,

Emre Durcan,

Humeyra Rekali Sahin,

Volkan Yumuk,

Taner Damcı,

Hasan İlkova,

Zeynep Oşar Şiva

Publication year - 2020

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2008-37

Subject(s) - medicine , pittsburgh sleep quality index , type 2 diabetes , diabetes mellitus , type 2 diabetes mellitus , quality of life (healthcare) , anxiety , body mass index , beck depression inventory , beck anxiety inventory , depression (economics) , physical therapy , vitality , sleep quality , psychiatry , endocrinology , insomnia , philosophy , nursing , macroeconomics , theology , economics

To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research